日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Complement activation and M2-like macrophage accumulation in anti-MDA5 monoclonal antibody-induced hepatic injury in mice.

抗MDA5单克隆抗体诱导小鼠肝损伤中补体激活和M2样巨噬细胞聚集。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1707202
Koga Takuma, Zaizen Yoshiaki, Suzuki Hiroyuki, Sugi Suzuna, Hozumi Hironao, Sakamoto Noriho, Suda Takafumi, Mukae Hiroshi, Kusano Hironori, Kawahara Akihiko, Akiba Jun, Kawaguchi Takumi, Kaieda Shinjiro, Hoshino Tomoaki
肝损伤
单克隆抗体
细胞生物学
巨噬细胞
巨噬细胞
发表日期：2026
文献求助 收藏

Solithromycin mitigates Prevotella intermedia-induced methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia by enhancing alveolar macrophage function

索利霉素通过增强肺泡巨噬细胞功能来减轻由中间普雷沃菌引起的耐甲氧西林金黄色葡萄球菌呼吸机相关性肺炎。

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2026.1723186
Fukushima, Koki; Iwanaga, Naoki; Ashizawa, Nobuyuki; Takeda, Kazuaki; Hirayama, Tatsuro; Yoshida, Masataka; Ide, Shotaro; Takazono, Takahiro; Kosai, Kosuke; Sakamoto, Noriho; Naito, Mariko; Yanagihara, Katsunori; Mukae, Hiroshi
肺炎
巨噬细胞
细胞生物学
巨噬细胞
免疫/内分泌
发表日期：2026
文献求助 收藏

Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)

尼达尼布联合抗炎药一线治疗进行性肺纤维化：一项多中心、单臂 2 期研究 (TOP-ILD)

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00697-2025
Tsubouchi, Kazuya; Hirose, Masayuki; Takei, Reoto; Fujisawa, Tomoyuki; Tobino, Kazunori; Ichiyasu, Hidenori; Izumi, Shinyu; Sakamoto, Noriho; Asami-Noyama, Maki; Nishiyama, Osamu; Waseda, Yuko; Nakanishi, Masanori; Baba, Tomohisa; Chiba, Hirofumi; Furusawa, Haruhiko; Zaizen, Yoshiaki; Ishii, Hiroshi; Okamoto, Masaki; Kondoh, Yasuhiro; Ogura, Takashi; Ichikado, Kazuya; Okamoto, Isamu
发表日期：2026
文献求助 收藏

Clinical Emergence of Bacteroides-Associated Anaerobic Bacteremia Due to Drug-Resistant Non-Bacteroides fragilis Species: A Multicentric Retrospective Observational Study

由耐药性非脆弱拟杆菌引起的拟杆菌相关厌氧菌血症的临床表现：一项多中心回顾性观察研究

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofag047
Kubo, Ryotaro; Iwanaga, Naoki; Nagaoka, Kentaro; Murai, Yushi; Ashizawa, Nobuyuki; Yoshida, Masataka; Takeda, Kazuaki; Ide, Shotaro; Takazono, Takahiro; Kosai, Kosuke; Morinaga, Yoshitomo; Sakamoto, Noriho; Yamamoto, Yoshihiro; Yanagihara, Katsunori; Mukae, Hiroshi
发表日期：2026
文献求助 收藏

Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study)

克拉霉素对轻度 COVID-19 肺炎的症状缓解和细胞因子调节作用：一项探索性、多中心、随机对照开放标签试验（CAME-COVID 研究）

期刊:Therapeutic Advances in Infectious Disease
影响因子:3.4
doi:10.1177/20499361261431488
Yamamoto, Kazuko; Iwanaga, Naoki; Umemura, Asuka; Sawai, Toyomitsu; Sumiyoshi, Makoto; Hashiguchi, Kohji; Mori, Yusuke; Ishii, Hiroshi; Futsuki, Yoji; Kiyohara, Maiko; Ota, Kenji; Kosai, Kosuke; Sasaki, Daisuke; Takamatsu, Yuki; Inoue, Shingo; Morita, Kouichi; Tsutsui, Shin; Ashizawa, Kazuto; Takazono, Takahiro; Sakamoto, Noriho; Hosogaya, Naoki; Tashiro, Masato; Tanaka, Takeshi; Izumikawa, Koichi; Yanagihara, Katsunori; Mukae, Hiroshi
肺炎
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor.

PARP抑制剂talazoparib在滑膜肉瘤中的新型治疗潜力及其与ATR抑制剂的联合作用。

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-026-04422-5
Honda Noritaka, Taniguchi Hirokazu, Ono Sawana, Hayashi Fumiko, Imamura Erika, Gyotoku Hiroshi, Takemoto Shinnosuke, Takazono Takahiro, Ishimoto Hiroshi, Sakamoto Noriho, Obase Yasushi, Masutani Mitsuko, Nishino Tomoya, Mukae Hiroshi
滑膜肉瘤
肿瘤
ATR
PARP
发表日期：2026
文献求助 收藏

Directed evolution of Clec12a-binding peptides using mammalian-expressed recombinant protein.

利用哺乳动物表达的重组蛋白对Clec12a结合肽进行定向进化。

期刊:Biochemistry and Biophysics Reports
影响因子:2.2
doi:10.1016/j.bbrep.2026.102531
Kawaguchi Yoshirou, Islam Md Samiul, Yokoyama Mina, Hosokawa Takanatsu, Nakaya Misuzu, Kamiya Noriho, Goto Masahiro
发表日期：2026
文献求助 收藏

Pre-treatment serum albumin predicts relapse in idiopathic inflammatory myopathies: a retrospective cohort study with cytokine profiling

治疗前血清白蛋白水平可预测特发性炎症性肌病复发：一项回顾性队列研究及细胞因子谱分析

期刊:Rheumatology Advances in Practice
影响因子:2.1
doi:10.1093/rap/rkag021
Matsuo, Haruna; Shimizu, Toshimasa; Koga, Tomohiro; Sakamoto, Noriho; Kawakami, Atsushi
炎症/感染
细胞生物学
炎症
免疫/内分泌
发表日期：2026
文献求助 收藏

Safety and effectiveness of a portable nasal high-flow device for improving exercise tolerance in patients with chronic obstructive pulmonary disease: a study protocol for an open-label, randomized, crossover pilot trial

便携式鼻腔高流量装置改善慢性阻塞性肺疾病患者运动耐量的安全性和有效性：一项开放标签、随机、交叉试验的研究方案

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-2025-aw-2316
Fukushima, Chizu; Fukahori, Susumu; Iriki, Jun; Tsukamoto, Yusei; Obase, Yasushi; Kozu, Ryo; Yanagita, Yorihide; Ayuse, Takao; Hosogaya, Naoki; Hanada, Masatoshi; Oikawa, Masato; Kawazoe, Yurika; Takemoto, Shinnosuke; Takazono, Takahiro; Sakamoto, Noriho; Nishino, Tomoya; Mukae, Hiroshi
慢性阻塞性肺疾病
发表日期：2026
文献求助 收藏

Transcription factor JUNB is required for transformation of EpCAM-positive hepatocellular carcinoma (HCC) cells into CD90-positive HCC cells in vitro.

转录因子 JUNB 是 EpCAM 阳性肝细胞癌 (HCC) 细胞在体外转化为 CD90 阳性 HCC 细胞所必需的

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07602-3
Kawakami Yutaro, Okada Hikari, Nio Kouki, Hayashi Tomoyuki, Seki Akihiro, Nakagawa Hidetoshi, Yamada Shinya, Iida Noriho, Shimakami Tetsuro, Takatori Hajime, Honda Masao, Kaneko Shuichi, Yamashita Taro
细胞生物学
CD9
CD90
肿瘤免疫
发表日期：2025
文献求助 收藏